超声引导下肝癌热消融的应用及进展

doi:10.11904/j.issn.1002-3070.2022.04.018

Abstract

Abstract: Liver cancer is one of the common malignant tumors in the clinic.The incidence of liver cancer ranks sixth among all kinds of malignant tumors in the world and is increasing year by year,which has seriously endangered people's health.The current main treatment methods include surgery,local thermal ablation,and liver transplantation.In recent years,local thermal ablation has become more and more widely used in liver malignancies.This article reviews the application of ultrasound-guided thermal ablation in liver cancer and related new technologies.

Key words: Liver cancer, Ultrasound, Thermal ablation

CLC Number:

R735.7

LI Lei, ZHANG Lei, CHENG Wen. Application and progress of ultrasound-guided thermal ablation of liver cancer[J]. Journal of Practical Oncology, 2022, 36(4): 386-390.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2022.04.018

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2022/V36/I4/386

References

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 李进军.多极射频消融仪治疗肝癌的研究进展[J].中国医疗器械信息,2021,27(14):20-21.
3 Nault JC,Sutter O,Nahon P,et al.Percutaneous treatment of hepatocellular carcinoma:state of the art and innovations[J].J Hepatol,2018,68(4):783-797.
4 Izzo F,Granata V,Grassi R,et al.Radiofrequency ablation and microwave ablation in liver tumors:an update[J].Oncologist,2019,24(10):990-1005.
5 Kawamura Y,Ikeda K,Shindoh J,et al.No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection[J].Hepatol Res,2019,49(2):164-176.
6 Huang Q,Li J,Zeng Q,et al.Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery[J].BMC Cancer,2020,20(1):763.
7 应希慧,张登科,陈丽,等.放射性粒子植入在原发性肝癌射频消融后应用人群的初步探讨[J].中华医学杂志,2020,(17):1310-1314.
8 Huang G,Lin M,Xie X,et al.Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma[J].Eur Radiol,2014,24(7):1565-1571.
9 Piskin FC,Balli HT,Aikimbaev K.Safety and efficacy analysis of microwave ablation in small hepatocellular carcinomas sized below 3 cm[J].Pol J Radiol,2020,85:202-208.
10 Chong C,Lee KF,Cheung S,et al.Prospective double-blinded randomized controlled trial of microwave versus radiofrequency ablation for hepatocellular carcinoma(mcRFA trial)[J].HPB(Oxford),2020,22(8):1121-1127.
11 Dong LN,Yu XL,Cheng ZG,et al.Comparison of parallel and crossed placement of antennas in microwave ablation of 3-5 cm hepatocellular carcinoma[J].Abdom Radiol(NY),2019,44(6):2293-2300.
12 凌云彪,张小丹,吴宇轩,等.超声引导下第二肝门旁肝细胞癌热消融疗效[J].中华肝脏外科手术学电子杂志,2020,9(5):479-483.
13 Orlacchio A,Bolacchi F,Chegai F,et al.Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm[J].Radiol Med,2014,119(5):298-308.
14 张丹,李曾,柏艳红,等.超声引导下激光与射频消融治疗小肝癌的临床疗效差异[J].肝脏,2019,24(6):666-669.
15 Chai W,Zhao Q,Kong D,et al.Percutaneous laser ablation of hepatic tumors located in the portacaval space:preliminary results[J].Lasers Surg Med,2019,51(10):866-873.
16 Ji Y,Zhu J,Zhu L,et al.High-intensity focused ultrasound ablation for unresectable primary and metastatic liver cancer:real-world research in a chinese tertiary center with 275 cases[J].Front Oncol,2020,10:519164.
17 Sun M,Shang P,Bai J,et al.High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer[J].J Clin Lab Anal,2021,35(2):23633.
18 Tsang SH,Ma KW,She WH,et al.High-intensity focused ultrasound ablation of liver tumors in difficult locations[J].Int J Hyperthermia,2021,38(2):56-64.
19 Mulier S,Ni Y,Jamart J,et al.Local recurrence after hepatic radiofrequency coagulation:multivariate meta-analysis and review of contributing factors[J].Ann Surg,2005,242(2):158-171.
20 陈良,刘艳芳,孙勤学,等.射频消融联合肝动脉化疗栓塞治疗直径3cm以上原发性肝癌的疗效和影响因素分析[J].现代实用医学,2019,31(5):590-592.
21 Smolock AR,Cristescu MM,Hinshaw A,et al.Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3~5 cm hepatocellular carcinoma when compared with transarterial chemoembolization alone[J].Abdom Radiol(NY),2018,43(9):2497-2504.
22 Gravante G,Sconocchia G,Ong SL,et al.Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies[J].Liver Int,2009,29(1):18-24.
23 Wang X,Liu G,Chen S,et al.Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma:a propensity score matching analysis[J].Int J Hyperthermia,2021,38(1):1519-1528.
24 Leuchte K,Staib E,Thelen M,et al.Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma[J].Cancer Immunol Immunother,2021,70(4):893-907.
25 Cheng AL,Kang YK,Chen Z,et al.Efficacy and safety of sorafenib in patients in the asia-pacific region with advanced hepatocellular carcinoma:a phase III randomised,double-blind,placebo-controlled trial[J].Lancet Oncol,2009,10(1):25-34.
26 付志豪,陈海明,王亚东,等.射频消融联合索拉菲尼治疗中晚期肝细胞癌的疗效及预后影响因素[J].重庆医学,2020,49(5):714-717.
27 Peng Z,Chen S,Wei M,et al.Advanced recurrent hepatocellular carcinoma:treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation[J].Radiology,2018,287(2):705-714.
28 Xu E,Long Y,Li K,et al.Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors[J].Int J Hyperthermia,2019,35(1):159-167.
29 Yosuke K,Kazushi N,Manabu M,et al.Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with GD-EOB-DTPA to detect small hepatocellular carcinoma[J].AJR,2012,198(1):106-114.
30 Li XQ,Wang X,Zhao DW,et al.Application of GD-EOB-DTPA-enhanced magnetic resonance imaging(MRI)in hepatocellular carcinoma[J].World J Surg Oncol,2020,18(1):219.
31 Calandri M,Mauri G,Yevich S,et al.Fusion imaging and virtual navigation to guide percutaneous thermal ablation of hepatocellular carcinoma:A review of the literature[J].Cardiovasc Intervent Radiol,2019,42(5):639-647.
32 Wu L,Chen J,Li K,et al.Potential application of ultrasound-guided thermal ablation in rare liver tumors[J].Hepatobiliary Pancreat Dis Int,2018,17(06):531-537.
33 Zhu Y,Xu JX,Cheng J,et al.A novel injectable thermo-sensitive binary hydrogels system for facilitating endoscopic submucosal dissection procedure[J].United European Gastroenterol J,2019,7(6):782-789.
34 Zhang L,Xia G,Liu Y,et al.Effect of a poloxamer 407-based thermosensitive gel on minimization of thermal injury to diaphragm during microwave ablation of the liver[J].World J Gastroenterol,2017,23(12):2141-2148.
35 Hu J,Chen S,Wang X,et al.Image-guided percutaneous microwave ablation versus cryoablation for hepatocellular carcinoma in high-risk locations:intermediate-term results[J].Cancer Manag Res,2019,11:9801-9811.
36 Lindner LH,Hossann M.Factors affecting drug release from liposomes[J].Curr Opin Drug Discov Devel,2010,13(1):111-123.
37 Jin Ys,Liang XL,An YK,et al.Microwave-triggered smart drug release from liposomes coencapsulating doxorubicin and salt for local combined hyperthermia and chemotherapy of cancer[J].Bioconjugate Chemistry,2016,27(12):2931-2942.
38 Zhang N,Wu Y,Xu W,et al.Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy[J].Drug Deliv,2022,29(1):506-518.

[1]	NA Jun, AN Xiaoxia, LI Xun, ZHANG Weiwei, MU Huijuan, LI Yanxia, PAN Guowei, LIU Li. Analysis of 10-year survival rate of liver cancer among residents in three cities of Liaoning province from 2000 to 2002 [J]. Journal of Practical Oncology, 2022, 36(4): 293-298.
[2]	TANG Rubing, WANG Qi, YOU Xuemei. Research progress in molecular mechanism of liver cancer comorbid and depression [J]. Journal of Practical Oncology, 2022, 36(3): 239-244.
[3]	CHEN He, WANG Qiucheng, CHENG Wen. The application progress of automatic breast ultrasound diagnosis system in breast cancer [J]. Journal of Practical Oncology, 2022, 36(2): 193-196.
[4]	GUO Lanwei, ZHANG Shaokai, LIU Shuzheng, ZHENG Liyang, CHEN Qiong, CAO Xiaoqin, SUN Xibin, ZHANG Jiangong. Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province [J]. Journal of Practical Oncology, 2021, 35(4): 307-313.
[5]	LI Min, RAN Li, CHANG Jianying. Application of imaging technology in image-guided brachytherapy for cervical cancer [J]. Journal of Practical Oncology, 2021, 35(3): 263-267.
[6]	ZHU Yunfang, CHEN Yang, ZHU Linfang, SHI Qingping, CHENG Huirong, REN Siying, WEN Hongmei. The incidence and mortality of liver cancer in Yunnan cancer registration areas in 2016 and the change trend from 2011 to 2016 [J]. Journal of Practical Oncology, 2021, 35(2): 97-102.
[7]	HU Qihui, DU Yichao, HE Kai, FU Wenguang, XIA Xianming. The role of endoplasmic reticulum stress in liver cancer [J]. Journal of Practical Oncology, 2021, 35(2): 160-164.
[8]	BAI Mingyu, CHEN Lili. Analytic death causes of liver cancer among urban residents in Yingkou city from 2015 to 2019 [J]. Journal of Practical Oncology, 2020, 34(6): 500-503.
[9]	LIU Hong, LU Hailing, CAI Li. Advances in imaging prediction of prognosis and neoadjuvant chemotherapy response in breast cancer patients [J]. Journal of Practical Oncology, 2020, 34(6): 535-539.
[10]	SHI Linna, SUI Hong. Progress and challenges of immune checkpoint inhibitor therapy for primary hepatocellular carcinoma [J]. Journal of Practical Oncology, 2020, 34(6): 560-564.
[11]	YUAN Yao, ZHOU Xianli. Research progress on the correlation between ultrasound features and axillary lymph node metastasis in breast cancer [J]. Journal of Practical Oncology, 2020, 34(6): 576-580.
[12]	ZHAO Rencheng, LIN Zitang, YU Weijun, LEI Lin, LIU Zheng, XU Ying, GUO Yanfang, PENG Ji. Analysis of the prevalence of five cancer risks among permanent residents aged 40~74 years old in Baoan District,Shenzhen,2017—2019 [J]. Journal of Practical Oncology, 2020, 34(4): 315-320.
[13]	LIU Siqi, BIAN Nana, SU Yajuan. Research on the value of ultrasound BI-RADS combined with serum CA15-3 and CEA in the diagnosis of breast tumors [J]. Journal of Practical Oncology, 2020, 34(4): 347-351.
[14]	QIN Kai,CHENG Yi,YUAN Xianglin,JIAN Dan′ni,ZHANG Jing,HUANG Le. Application value of utrasound bladder volume monitoring technology in intensity modulated radiotherapy for cervical cancer after operation [J]. Journal of Practical Oncology, 2020, 34(3): 232-236.
[15]	LI Susu, ZHOU Chunxiang. Two-way regulation of NKT cells on immune response to liver cancer [J]. Journal of Practical Oncology, 2019, 33(6): 540-543.

Application and progress of ultrasound-guided thermal ablation of liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments